Catalyst Wire Dossier Catalyst Wire Dossier

Autologous NKT cell therapy

autologous natural killer T (NKT) cells · Peking University Cancer Hospital & Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous NKT cell therapy, covering 2015-12-04 to 2015-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients [Phase 1]

See pricing